fda warning letters glp-1 september 2025 takes aim at Hims & Hers, weight loss drugs in new advertising blitz FDA Issues Warning Letters to

If you take one of these medications, which include lithium, valproate (Depakote), and lamotrigine (Lamictal XR), you can ask your prescriber to order labs so you can get a baseline

Through the companys collaboration with national virtual primary care provider LifeMD (Nasdaq: LFMD) and its affiliated medical group, customers now have access to GLP-1 medications where clinically appropriate

Adequate protein intake supports muscle mass and bone health, both of which become more important during periods of weight change

Compounded semaglutide is prepared by a licensed compounding pharmacy and is not FDA-approved as a finished drug product

They analyzed electronic medical data from health care institutions providing 18% of the daily clinical care in the U.S

GLP-1nutrition.com also offers assistance with personalized diet, lifestyle, and supplement questions through Nutrition Coach